Waters Corporation $WAT Shares Bought by Jupiter Asset Management Ltd.

Jupiter Asset Management Ltd. increased its holdings in Waters Corporation (NYSE:WAT) by 307.6% in the 2nd quarter, HoldingsChannel reports. The institutional investor owned 287,316 shares of the medical instruments supplier’s stock after buying an additional 216,825 shares during the period. Waters makes up about 0.8% of Jupiter Asset Management Ltd.’s portfolio, making the stock its 20th largest holding. Jupiter Asset Management Ltd.’s holdings in Waters were worth $100,285,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also recently bought and sold shares of the business. Zions Bancorporation National Association UT acquired a new position in Waters in the first quarter valued at approximately $28,000. IFP Advisors Inc lifted its holdings in shares of Waters by 118.9% in the 1st quarter. IFP Advisors Inc now owns 81 shares of the medical instruments supplier’s stock worth $30,000 after purchasing an additional 44 shares during the last quarter. Caitong International Asset Management Co. Ltd bought a new stake in shares of Waters in the 1st quarter worth approximately $41,000. Creative Financial Designs Inc. ADV boosted its position in Waters by 533.3% during the 2nd quarter. Creative Financial Designs Inc. ADV now owns 190 shares of the medical instruments supplier’s stock valued at $66,000 after purchasing an additional 160 shares during the period. Finally, Steph & Co. bought a new position in Waters during the 2nd quarter worth $73,000. Institutional investors and hedge funds own 94.01% of the company’s stock.

Waters Stock Up 2.6%

Waters stock opened at $386.37 on Wednesday. Waters Corporation has a 52 week low of $275.05 and a 52 week high of $423.56. The stock has a market cap of $23.00 billion, a price-to-earnings ratio of 34.84, a PEG ratio of 3.19 and a beta of 1.11. The company’s 50-day moving average price is $326.85 and its two-hundred day moving average price is $326.62. The company has a current ratio of 1.75, a quick ratio of 1.22 and a debt-to-equity ratio of 0.55.

Waters (NYSE:WAT) last posted its quarterly earnings data on Thursday, May 19th. The medical instruments supplier reported $2.29 EPS for the quarter. Waters had a net margin of 21.71% and a return on equity of 38.60%. The business had revenue of $608.55 million for the quarter. On average, analysts expect that Waters Corporation will post 12.86 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

Several equities analysts have recently issued reports on WAT shares. UBS Group reissued a “neutral” rating on shares of Waters in a report on Tuesday, July 15th. Weiss Ratings reissued a “hold (c)” rating on shares of Waters in a research note on Wednesday, October 8th. Robert W. Baird decreased their target price on shares of Waters from $374.00 to $352.00 and set an “outperform” rating for the company in a research report on Wednesday, July 16th. Rothschild Redb raised Waters to a “strong-buy” rating in a report on Wednesday, October 8th. Finally, Jefferies Financial Group set a $385.00 price objective on Waters and gave the stock a “buy” rating in a research report on Monday, August 4th. Two analysts have rated the stock with a Strong Buy rating, six have issued a Buy rating and nine have given a Hold rating to the company’s stock. According to MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $381.57.

About Waters

Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments: Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans.